bioRxiv Science⌕ Search

Biology subjects

Thomsen, E. A.

Publications and source records attributed to Thomsen, E. A..

2 recordsLinked to original sources

Mechanical stretch regulates inflammatory signaling in human smooth muscle cells

Background and aimsVascular smooth muscle cells (SMCs) cultured under standard static conditions adopt a modulated phenotype that resembles the SMC states found in atherosclerotic plaques, but the mechanical determinants of this drift are not well defined. We investigated how mechanical loading shapes SMC phenotype and inflammatory signaling. MethodsHuman aortic SMCs were maintained under static conditions, physiological cyclic stretch (10% elongation), or pathological stretch (15% elongation) and analyzed by bulk and single-cell RNA sequencing. Mechanistic experiments included siRNA-mediated knockdown of IKBKB, p65 immunofluorescence, and regulon inference from single-cell transcriptomes. ResultsStretch regulated cell cycle, contractile, and inflammatory gene programs in an intensity-dependent manner: 10% stretch suppressed basal and TNF-induced inflammatory gene expression, whereas 15% stretch did not. The anti-inflammatory effect of physiological stretch required IKBKB, yet the proportion of cells with nuclear p65 was unchanged, indicating that stretch constrains NF-{kappa}B output downstream of p65 nuclear entry rather than by blocking translocation. Single-cell RNA sequencing resolved nine states for SMCs in culture whose transcriptomes overlapped substantially with the modulated mesenchymal populations of human coronary and carotid plaques, and physiological stretch attenuated pro-inflammatory gene expression across the major clusters. Regulatory network analysis identified inflammatory transcription factors (RELB, CEBPB/D, IRF1/2, STAT2) as less active under physiological stretch, whereas mechano-lineage regulators (MEF2C, TEAD1, SMAD6) were selectively induced, providing candidate mediators of the effect. ConclusionsStatic culture represents a disease-like SMC baseline that physiological stretch attenuates, in part by constraining NF-{kappa}B transcriptional output at a step downstream of p65 nuclear entry. Graphical abstractPhysiological stretch (10%) maintains a low-inflammatory, healthy-like state in human aortic smooth muscle cells, whereas its absence (static culture) or excess (15% stretch) favors an inflammatory, plaque-like state. NF-{kappa}B-p65 enters the nucleus under all conditions; physiological stretch constrains its inflammatory output downstream of nuclear entry. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC="FIGDIR/small/685276v2_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@bbcf58org.highwire.dtl.DTLVardef@29ba95org.highwire.dtl.DTLVardef@1989aa4org.highwire.dtl.DTLVardef@1d0c253_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗

Resistance to vincristine in cancerous B-cells by disruption of p53-dependent mitotic surveillance

The frontline therapy R-CHOP for patients with diffuse large B-cell lymphoma (DLBCL) has remained unchanged for two decades despite numerous phase III clinical trials investigating new alternatives. Multiple large studies have uncovered genetic subtypes of DLBCL enabling a targeted approach. To further pave the way for precision oncology, we perform genome-wide CRISPR screening to uncover the cellular response to one of the components of R-CHOP, vincristine, in the DLBCL cell line SU-DHL-5. We discover important pathways and subnetworks using gene-set enrichment analysis and protein-protein interaction networks and identify genes related to mitotic spindle organization that are essential during vincristine treatment. Inhibition of KIF18A, a mediator of chromosome alignment, using the small molecule inhibitor BTB-1 causes complete cell death in a synergistic manner when administered together with vincristine. We also identify the genes KIF18B and USP28 for which CRISPR/Cas9-directed knockout induces vincristine resistance across two DLBCL cell lines. Mechanistic studies show that lack of KIF18B or USP28 counteracts a vincristine-induced p53 response involving the mitotic surveillance pathway (USP28-53BP1-p53). Collectively, our CRISPR screening data uncover potential drug targets and mechanisms behind vincristine resistance, which may support the development of future drug regimens. Key pointsO_LIInhibition of the mitotic surveillance pathway (USP28-53BP1-p53) and KIF18B induces resistance to vincristine C_LIO_LISubstantial synergistic effects observed when using the KIF18A-inhibitor BTB-1 with vincristine in eradicating GCB-subtype DLBCL cells C_LI

cancer biology↗